Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients.

Karin CernaDana DuricovaMiroslav HindosJana Hindos HrebackovaMartin LukasNadezda MachkovaVeronika HrubaKatarina MitrovaKristyna KubickovaKristyna KastylovaVladimir TeplanMilan Lukas

Published in: Journal of Crohn's & colitis (2022)

Simple humoral and cellular post-vaccination monitoring is advisable in IBD patients so that repeated vaccine doses may be scheduled.

Keyphrases

immune response
end stage renal disease
sars cov
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
dendritic cells